United States · FDA National Drug Code directory
PRAVASTATIN SODIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-0168_23a54cde-a404-07d5-9a4f-e7297930c0e5
- Product NDC
- 60505-0168
- Form
- TABLET
- Composition / generic term
- PRAVASTATIN SODIUM
- Labeler
- Apotex Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110718
- Source listing expiry
- 20271231
Source-listed ingredients
- PRAVASTATIN SODIUM — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (60505-0168-1) · 60505-0168-1
- 40000 TABLET in 1 BOTTLE (60505-0168-4) · 60505-0168-4
- 500 TABLET in 1 BOTTLE (60505-0168-5) · 60505-0168-5
- 1000 TABLET in 1 BOTTLE (60505-0168-7) · 60505-0168-7
- 90 TABLET in 1 BOTTLE (60505-0168-9) · 60505-0168-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →